MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-29-0082149
R2 Hemostasis Diagnostics India Private Limited - healthcare in Ghaziabad, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.76 Cr
▲ 30% YoY
Net loss · FY 2025
₹2.32 Lakh
Net margin -0.4%
EBITDA · FY 2025
₹85,326
EBITDA margin 0.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹79.36 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About R2 Hemostasis Diagnostics India Private Limited
Data last updated:
R2 Hemostasis Diagnostics India Private Limited is a foreign private limited company based in Ghaziabad, Uttar Pradesh, India, a subsidiary of Nzymes Research Laboratories. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 15 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74992UP2010FTC041987. Its GSTIN is 09AAECR9990B1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹79.36 Lakh. It is led by directors including Sumit Agarwal and Michael Joseph Morris.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ff – 26 Omaxe Park Plaza Indirapuram Shakti Khand – 2, Ghaziabad, Uttar Pradesh, India – 201010.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.76 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹2.32 Lakh (net margin -0.4%) and EBITDA of ₹85,326 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 15% over five years.
R2 Hemostasis Diagnostics India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0082149). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website r2diagnostics.com.
Company details
CIN U74992UP2010FTC041987
Registration Number 041987
Incorporation Date 15 September 2010
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Nzymes Research Laboratories
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-29-0082149
Recognitions & Rankings of R2 Hemostasis Diagnostics India
Contact details
R2 Hemostasis Diagnostics India Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its website is r2diagnostics.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressFf – 26 Omaxe Park Plaza Indirapuram Shakti Khand – 2, Ghaziabad, Uttar Pradesh, India – 201010
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of R2 Hemostasis Diagnostics India Private Limited, buy the company report.
Comprehensive company report
R2 Hemostasis Diagnostics India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of R2 Hemostasis Diagnostics India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of R2 Hemostasis Diagnostics India Private Limited, buy the company report.
Financials of R2 Hemostasis Diagnostics India Private Limited
FY 2025 filings availableR2 Hemostasis Diagnostics India Private Limited reported revenue of ₹5.76 Cr (up 30% YoY) for FY 2025.
Revenue · FY 2025
₹5.76 Cr ▲ 30%
Net loss · FY 2025
₹2.32 Lakh margin -0.4%
EBITDA · FY 2025
₹85,326 margin 0.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▼ 6%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 105%
3 years · compounded
▼ 76%
5 years · compounded
▼ 50%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 30% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹85,326 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of R2 Hemostasis Diagnostics India Private Limited, buy the company report.
Board of directors of R2 Hemostasis Diagnostics India Private Limited
R2 Hemostasis Diagnostics India has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Agarwal | Director | 24 Dec 2014 | 11 Years 10 Months | Current |
| Michael Joseph Morris Also directs: Coagnostics Private Limited | Director | 15 Sep 2010 | 16 Years 1 Months | Current |
| Daniel J Smogor | Director | 15 Sep 2010 | 16 Years 1 Months | Current |
Peer comparison
R2 Hemostasis Diagnostics India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shanti Ved Institute of Medical Sciences Private Limited | ₹5.83 Cr (FY 2025) | -20.0% | Agra, Uttar Pradesh, India | |||
| Apur Medico Private Limited | ₹5.82 Cr (FY 2024) | -5.0% | Uttar Pradesh, India | |||
| Oscar Diagnostic Services Private Limited | ₹5.78 Cr (FY 2022) | 38.0% | New Delhi, Delhi, India | |||
| R2 Hemostasis Diagnostics India Private Limitedthis company | ₹5.76 Cr (FY 2025) | -₹2.32 Lakh | -0.4% | 30.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of R2 Hemostasis Diagnostics India Private Limited, buy the company report.
Auditor
R2 Hemostasis Diagnostics India Private Limited is audited by AKHIL JINDAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKHIL JINDAL & CO | FY 2023 | 025124C |
Shareholding
The shareholding of R2 Hemostasis Diagnostics India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of R2 Hemostasis Diagnostics India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving R2 Hemostasis Diagnostics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for R2 Hemostasis Diagnostics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
R2 Hemostasis Diagnostics India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECR9990B1Z0 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of R2 Hemostasis Diagnostics India Private Limited, buy the company report.
Recent activity
R2 Hemostasis Diagnostics India Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Sumit Agarwal was appointed as Director on 24 Dec 2014.
AGM
R2 Hemostasis Diagnostics India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
R2 Hemostasis Diagnostics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Appointed
Sumit Agarwal was appointed as Director.
Appointed
Daniel J Smogor was appointed as Director.
Appointed
Michael Joseph Morris was appointed as Director.
Incorporation
15 Sep 2010
R2 Hemostasis Diagnostics India Private Limited was registered on 15 Sep 2010 with Roc Uttar Pradesh Ii & aged 16 years 1 month as per MCA records.
Frequently asked questions
R2 Hemostasis Diagnostics India is an active foreign private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 15 September 2010 (16+ years old) and is registered under CIN U74992UP2010FTC041987.
R2 Hemostasis Diagnostics India has 3 current directors:
- Sumit Agarwal - Director
- Michael Joseph Morris - Director
- Daniel J Smogor - Director
The latest financial statements of R2 Hemostasis Diagnostics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of R2 Hemostasis Diagnostics India is 09AAECR9990B1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of R2 Hemostasis Diagnostics India is U74992UP2010FTC041987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R2 Hemostasis Diagnostics India was incorporated on 15 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of R2 Hemostasis Diagnostics India by revenue are Shanti Ved Institute of Medical Sciences Private Limited, Apur Medico Private Limited, Oscar Diagnostic Services Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Sumit Agarwal was appointed as Director on 24 Dec 2014. Daniel J Smogor was appointed as Director on 15 Sep 2010. Michael Joseph Morris was appointed as Director on 15 Sep 2010.
Yes, R2 Hemostasis Diagnostics India is registered as a small enterprise under Udyam registration (number: UDYAM-UP-29-0082149).
R2 Hemostasis Diagnostics India can be reached through the website r2diagnostics.com. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The registered office of R2 Hemostasis Diagnostics India is at Ff – 26 Omaxe Park Plaza Indirapuram Shakti Khand – 2, Ghaziabad, Uttar Pradesh, India – 201010.